Pierre Fontana

Pierre Fontana

Division of Angiology and Haemostasis & Geneva Platelet Group, Geneva University Hospitals

Affiliated withGeneva University Hospitals

Research Area

Biography

Pierre Fontana has not added Biography.
If you are Pierre Fontana and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Publication title

Cited by 5

2017

Other Publications

Article
Year
An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN.

Blood| PubMed ID: 12406873

2003
2003
2003
2004
2004
2004
2003
2005
Physiological plasma Gas6 levels do not influence platelet aggregation.

Arteriosclerosis, thrombosis, and vascular biology| PubMed ID: 16484600

2006
2006
2006
2008
Laboratory-defined aspirin resistance and recurrent cardiovascular events.

Archives of internal medicine| PubMed ID: 18332305

2008
2008
Aspirin response variability assessed with the PFA-100 device.

Thrombosis and haemostasis| PubMed ID: 18449432

2008
Intercellular communication in atherosclerosis.

Physiology (Bethesda, Md.)| PubMed ID: 19196650

2009
2009
[The new antithrombotics in 2009].

Revue medicale suisse| PubMed ID: 19271646

2009
Cell-derived microparticles in haemostasis and vascular medicine.

Thrombosis and haemostasis| PubMed ID: 19277403

2009
2009
2009
Diagnosis of mild bleeding disorders.

Swiss medical weekly| PubMed ID: 19529990

2009
2009
2010
2012
2011
2011
Platelet proteomics.

Mass spectrometry reviews| PubMed ID: 22009795

2012
[Monitoring of heparins and of anticoagulants].

Revue medicale suisse| PubMed ID: 22073696

2011
2012
2012
Aspirin for venous thromboembolism prevention and treatment: a renewal?

Polskie Archiwum Medycyny Wewnetrznej| PubMed ID: 23123525

2012
Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping.

Journal of the American Heart Association| PubMed ID: 23537811

2013
2013
2013
2013
Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis| PubMed ID: 24389539

2014
2014
How to manage prasugrel and ticagrelor in daily practice.

European journal of internal medicine| PubMed ID: 24529662

2014
2014
[Aspirin: once or twice a day?].

Revue medicale suisse| PubMed ID: 24558899

2014
2014
2014
2015
2015
2015
2015
2015
2015
2015
2015
2015
2016
2015
2016
2016
Pharmacogenomics of Oral Antithrombotic Drugs.

Current pharmaceutical design| PubMed ID: 26642774

2016
2016
[News in angiology and hemostasis].

Revue medicale suisse| PubMed ID: 26946695

2016
Direct oral anticoagulants: a guide for daily practice.

Swiss medical weekly| PubMed ID: 26964028

2016
2016
2016
2016
2016
2016
2016
2017
2016
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect.

Frontiers in pharmacology| PubMed ID: 28066243

2016
2017
Impact of rivaroxaban on point-of-care assays.

Thrombosis research| PubMed ID: 28343143

2017